ARDX - Ardelyx, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Ardelyx, Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases.
IPO Date: June 19, 2014
Sector: Healthcare
Industry: Biotech
Market Cap: $844.27M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.24 | 3.52%
Avg Daily Range (30 D): $0.06 | 1.65%
Avg Daily Range (90 D): $0.11 | 2.36%
Institutional Daily Volume
Avg Daily Volume: 2.51M
Avg Daily Volume (30 D): 3.41M
Avg Daily Volume (90 D): 3.48M
Trade Size
Avg Trade Size (Sh.): 250
Avg Trade Size (Sh.) (30 D): 205
Avg Trade Size (Sh.) (90 D): 173
Institutional Trades
Total Institutional Trades: 1,904
Avg Institutional Trade: $2.19M
Avg Institutional Trade (30 D): $2.66M
Avg Institutional Trade (90 D): $2.67M
Avg Institutional Trade Volume: .42M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.91M
Avg Closing Trade (30 D): $2.83M
Avg Closing Trade (90 D): $3.19M
Avg Closing Volume: 545.13K
 
News
Oct 9, 2026 @ 9:12 AM
New Strong Sell Stocks for October 9th
Source: Na
Oct 9, 2026 @ 12:47 AM
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ardelyx...
Source: Rosen Law Firm
Oct 9, 2026 @ 12:02 AM
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Him...
Source: Rosen Law Firm
Oct 7, 2026 @ 6:23 AM
New Strong Sell Stocks for October 7th
Source: Na
Oct 6, 2026 @ 11:00 AM
Lead Plaintiff Deadlines in Shareholder Class Acti...
Source: Holzer & Holzer, Llc
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.23 $-.07 $-.15
Diluted EPS $-.23 $-.07 $-.15
Revenue $450.89M $120.88M $94.47M
Gross Profit $425.49M $115.12M $89.66M
Net Income / Loss $-55.7M $-16.72M $-37.61M
Operating Income / Loss $-35.45M $-12.43M $-32.79M
Cost of Revenue $25.4M $5.76M $4.81M
Net Cash Flow $7.15M
PE Ratio